LDLR rs121908487: Understanding the p.Asp227Glu Variant

What each genotype means

What is the rs121908487 Variant?

The rs121908487 variant is a single nucleotide polymorphism (SNP) located within the LDLR gene on chromosome 19. In genetic terms, this variant represents a specific change where a cytosine (C) is replaced by a guanine (G) at a precise position in the DNA sequence. This change leads to a missense mutation, meaning the protein-building instructions are altered such that the amino acid aspartic acid (Asp) is replaced by glutamic acid (Glu) at position 227 of the LDL receptor protein. Because the LDL receptor is a critical component of cholesterol metabolism, even small changes in its structure can have significant functional consequences. This variant is cataloged in clinical databases as a pathogenic or likely pathogenic change, meaning it is recognized by the medical genetics community as a factor that can disrupt normal biological processes.

The Role of the LDLR Gene

The LDLR gene provides the blueprint for the low-density lipoprotein receptor, a protein found on the surface of cells, particularly in the liver. The primary function of this receptor is to bind to LDL particles—often referred to as 'bad' cholesterol—circulating in the blood and pull them into the cell through a process called receptor-mediated endocytosis. Once inside the cell, the cholesterol is processed, which helps maintain healthy levels of circulating lipids. When the LDLR gene contains a pathogenic variant, the resulting receptor may be produced in insufficient quantities, fail to reach the cell surface, or lose its ability to bind and internalize LDL particles effectively. This dysfunction leads to an accumulation of LDL cholesterol in the bloodstream, which is a hallmark of familial hypercholesterolemia, a condition that can increase the risk of premature cardiovascular disease.

Research and Clinical Associations

Scientific research has established a strong link between variants in the LDLR gene and familial hypercholesterolemia. The rs121908487 variant, specifically, has been identified in multiple clinical submissions as a pathogenic or likely pathogenic factor. Studies investigating the functional landscape of LDLR variants have shown that mutations affecting the receptor's structure often correlate with reduced LDL uptake capacity in laboratory models. While the evidence for this specific variant is supported by clinical observations and its classification in databases like ClinVar, it is important to note that the clinical expression of familial hypercholesterolemia can vary between individuals. Factors such as other genetic modifiers, lifestyle, and diet also play significant roles in determining an individual's cholesterol levels and overall cardiovascular risk. Genetic testing for this variant is typically performed in a clinical setting to help clarify the cause of elevated cholesterol levels in families.

Population Frequency

The rs121908487 variant is considered rare in the general population. It is not a common polymorphism found in the majority of individuals. Instead, its presence is more frequently observed in specific cohorts of patients who have been clinically diagnosed with familial hypercholesterolemia. Because it is a rare variant, it is not typically included in standard, broad-spectrum ancestry-based genetic screening panels. Its identification usually occurs through targeted diagnostic testing for individuals with a personal or family history of severe hypercholesterolemia. The rarity of this variant underscores that it is not a common cause of cholesterol variation in the general public, but rather a specific genetic driver identified in clinical settings where hereditary lipid disorders are suspected.

Interpreting Your Genetic Information

If you have received information regarding the rs121908487 variant, it is essential to understand that this is a clinical finding that requires professional interpretation. Genetic results should never be used to self-diagnose or make independent medical decisions. If this variant is present, it may suggest a genetic predisposition to familial hypercholesterolemia, but it does not provide a complete picture of your health. You should discuss these results with a healthcare provider, such as a cardiologist or a genetic counselor, who can place the finding in the context of your personal medical history, physical exams, and blood lipid panels. They can provide guidance on appropriate screening, lifestyle adjustments, or potential medical management. Always consult with your clinician or pharmacist before making any changes to medications or treatment plans, as they are the only ones qualified to provide personalized medical advice.

Frequently asked questions

Sources & further reading

Related variants in LDLR